N-ethylmaleimide-sensitive factor: A redox sensor in exocytosis

Biological Chemistry

Volumn 387, Issue 10-11, 2006, Pages 1377-1383

  Lowenstein, Charles J ^a   Tsuda, Hiromasa ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelial cell; Hydrogen peroxide; Nitric oxide; Peroxynitrite; Platelet; Reactive oxygen species; Superoxide; Weibel Palade bodies

Indexed keywords

CYSTEINE; HYDROGEN PEROXIDE; N ETHYLMALEIMIDE SENSITIVE FACTOR; NITRIC OXIDE; SNARE PROTEIN;

CONFERENCE PAPER; EXOCYTOSIS; LEUKOCYTE; MUTAGENESIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; WEIBEL PALADE BODY;

ANIMALS; CELL MOVEMENT; EXOCYTOSIS; HUMANS; LEUKOCYTES; N-ETHYLMALEIMIDE-SENSITIVE PROTEINS; NITRIC OXIDE; OXIDATION-REDUCTION;

EID: 33750610483     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.173     Document Type: Conference Paper

References (79)

1. Ahluwalia, A., Foster, P., Scotland, R.S., McLean, P.G., Mathur, A., Perretti, M., Moncada, S., and Hobbs, A.J. (2004). Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc. Natl. Acad. Sci. USA 101, 1386-1391.
2. 2+-dependent multivalent binding of synaptotagmin-1 to phospholipids. Nat. Struct. Mol. Biol. 13, 209-217.
3. Babor, S.M. and Fass, D. (1999). Crystal structure of the Sec18p N-terminal domain. Proc. Natl. Acad. Sci. USA 96, 14759-14764.
4. 2+-activated exocytosis. J. Biol. Chem. 271, 20223-20226.
5. Beghetti, M., Sparling, C., Cox, P.N., Stephens, D., and Adatia, I. (2003). Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers. Am. J. Physiol. Heart Circ. Physiol. 285, H637-H642.
6. Bittner, M.A. and Holz, R.W. (1992). Kinetic analysis of secretion from permeabilized adrenal chromaffin cells reveals distinct components. J. Biol. Chem. 267, 16219-16225.
7. Block, M.R., Glick, B.S., Wilcox, C.A., Wieland, F.T., and Rothman, J.E. (1988). Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular transport. Proc. Natl. Acad. Sci. USA 85, 7852-7856.
8. Brune, B. and Lapetina, E.G. (1990). Properties of a novel nitric oxide-stimulated ADP-ribosyltransferase. Arch. Biochem. Biophys. 279, 286-290.
9. Burgoyne, R.D. and Morgan, A. (1998). Analysis of regulated exocytosis in adrenal chromaffin cells: insights into NSF/SNAP/SNARE function. Bioessays 20, 328-335.
10. Busse, R., Luckhoff, A., and Bassenge, E. (1987). Endothelium-derived relaxant factor inhibits platelet activation. Naunyn-Schmiedeberg's Arch. Pharmacol. 336, 566-571.
11. Cai, H. and Harrison, D.G. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844.
12. Cai, H., Griendling, K.K., and Harrison, D.G. (2003). The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471-478.
13. Chen, D., Bernstein, A.M., Lemons, P.P., and Whiteheart, S.W. (2000a). Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release. Blood 95, 921-929.
14. Chen, D., Lemons, P.P., Schraw, T., and Whiteheart, S.W. (2000b). Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood 96, 1782-1788.
15. Christopherson, K.S. and Bredt, D.S. (1997). Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. Invest. 100, 2424-2429.
16. Davignon, J. and Ganz, P. (2004). Role of endothelial dysfunction in atherosclerosis. Circulation 109, III27-32.
17. De Caterina, R., Libby, P., Peng, H.B., Thannickal, V.J., Rajavashisth, T.B., Gimbrone, M.A. Jr., Shin, W.S., and Liao, J.K. (1995). Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96, 60-68.
18. Feil, R., Lohmann, S.M., de Jonge, H., Walter, U., and Hofmann, F. (2003). Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ. Res. 93, 907-916.
19. Feng, D., Crane, K., Rozenvayn, N., Dvorak, A.M., and Flaumenhaft, R. (2002). Subcellular distribution of three functional platelet SNARE proteins: human cellubrevin, SNAP-23, and syntaxin 2. Blood 99, 4006-4014.
20. Furchgott, R.F. and Vanhoutte, P.M. (1989). Endothelium-derived relaxing and contracting factors. FASEB J. 3, 2007-2018.
21. Gordge, M.P., Hothersall, J.S., and Noronha-Dutra, A.A. (1998). Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br. J. Pharmacol. 124, 141-148.
22. Hanson, P.I., Roth, R., Morisaki, H., Jahn, R., and Heuser, J.E. (1997). Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy. Cell 90, 523-535.
23. Ignarro, L.J. (1990). Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67, 1-7.
24. Jaffrey, S.R., Erdjument-Bromage, H., Ferris, C.D., Tempst, P., and Snyder, S.H. (2001). Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3, 193-197.
25. Jahn, R. and Sudhof, T.C. (1999). Membrane fusion and exocytosis. Annu. Rev. Biochem. 68, 863-911.
26. Kubes, P., Suzuki, M., and Granger, D.N. (1991). Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88, 4651-4655.
27. Kuhlencordt, P.J., Chen, J., Han, F., Astern, J., and Huang, P.L. (2001a). Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103, 3099-3104.
28. Kuhlencordt, P.J., Gyurko, R., Han, F., Scherrer-Crosbie, M., Aretz, T.H., Hajjar, R., Picard, M.H., and Huang, P.L. (2001b). Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448-454.
29. Kuhlencordt, P.J., Rosel, E., Gerszten, R.E., Morales-Ruiz, M., Dombkowski, D., Atkinson, W.J., Han, F., Preffer, F., Rosenzweig, A., Sessa, W.C., et al. (2004). Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. Am. J. Physiol. Cell Physiol. 286, C1195-C1202.
30. Lemons, P.P., Chen, D., Bernstein, A.M., Bennett, M.K., and Whiteheart, S.W. (1997). Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood 90, 1490-1500.
31. Lemons, P.P., Chen, D., and Whiteheart, S.W. (2000). Molecular mechanisms of platelet exocytosis: requirements for α-granule release. Biochem. Biophys. Res. Commun. 267, 875-880.
32. Lenzen, C.U., Steinmann, D., Whiteheart, S.W., and Weis, W.I. (1998). Crystal structure of the hexamerization domain of N-ethylmaleimide-sensitive fusion protein. Cell 94, 525-536.
33. Lin, R.C. and Scheller, R.H. (2000). Mechanisms of synaptic vesicle exocytosis. Annu. Rev. Cell Dev. Biol. 16, 19-49.
34. Littleton, J.T. and Bellen, H.J. (1995). Presynaptic proteins involved in exocytosis in Drosophila melanogaster: a genetic analysis. Invert. Neurosci. 1, 3-13.
35. Littleton, J.T., Chapman, E.R., Kreber, R., Garment, M.B., Carlson, S.D., and Ganetzky, B. (1998). Temperature-sensitive paralytic mutations demonstrate that synaptic exocytosis requires SNARE complex assembly and disassembly. Neuron 21, 401-413.
36. Loscalzo, J. (1992). Antiplatelet and antithrombotic effects of organic nitrates. Am. J. Cardiol. 70, 18B-22B.
37. Loscalzo, J. (2001). Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ. Res. 88, 756-762.
38. Lowenstein, C.J., Morrell, C.N., and Yamakuchi, M. (2005). Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc. Med. 15, 302-308.
39. Malhotra, V., Orci, L., Glick, B.S., Block, M.R., and Rothman, J.E. (1988). Role of an N-ethylmaleimide-sensitive transport component in promoting fusion of transport vesicles with cisternae of the Golgi stack. Cell 54, 221-227.
40. Marletta, M.A., Tayeh, M.A., and Hevel, J.M. (1990). Unraveling the biological significance of nitric oxide. Biofactors 2, 219-225.
41. Marshall, H.E. and Stamler, J.S. (2001). Inhibition of NF-κB by S-nitrosylation. Biochemistry 40, 1688-1693.
42. Matsushita, K., Morrell, C.N., Cambien, B., Yang, S.X., Yamakuchi, M., Bao, C., Hara, M.R., Quick, R.A., Cao, W., O'Rourke, B., et al. (2003). Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115, 139-150.
43. Matsushita, K., Morrell, C.N., Mason, R.J., Yamakuchi, M., Khanday, F.A., Irani, K., and Lowenstein, C.J. (2005). Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N-ethylmaleimide sensitive factor. J. Cell Biol. 170, 73-79.
44. Matthews, J.R., Botting, C.H., Panico, M., Morris, H.R., and Hay, R.T. (1996). Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res. 24, 2236-2242.
45. Mayer, A. and Wickner, W. (1997). Docking of yeast vacuoles is catalyzed by the Ras-like GTPase Ypt7p after symmetric priming by Sec18p (NSF). J. Cell Biol. 136, 307-317.
46. Mayer, A., Wickner, W., and Haas, A. (1996). Sec18p (NSF)-driven release of Sec17p (α-SNAP) can precede docking and fusion of yeast vacuoles. Cell 85, 83-94.
47. McBride, H.M., Rybin, V., Murphy, C., Giner, A., Teasdale, R., and Zerial, M. (1999). Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between EEA1 and syntaxin 13. Cell 98, 377-386.
48. McDonald, L.J. and Murad, F. (1995). Nitric oxide and cGMP signaling. Adv. Pharmacol. 34, 263-275.
49. Mellion, B.T., Ignarro, L.J., Ohlstein, E.H., Pontecorvo, E.G., Hyman, A.L., and Kadowitz, P.J. (1981). Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57, 946-955.
50. Mendelsohn, M.E., O'Neill, S., George, D., and Loscalzo, J. (1990). Inhibition of fibrinogen binding to human platelets by S-nitroso N-acetylcysteine. J. Biol. Chem. 265, 19028-19034.
51. Michel, T. and Feron, O. (1997). Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 100, 2146-2152.
52. Morgan, A. (1996). Classic clues to NSF function. Nature 382, 680.
53. Moro, M.A., Russel, R.J., Cellek, S., Lizasoain, I., Su, Y., Darley-Usmar, V.M., Radomski, M.W., and Moncada, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA 93, 1480-1485.
54. Morrell, C.N., Matsushita, K., Chiles, K., Scharpf, R.B., Yamakuchi, M., Mason, R.J., Bergmeier, W., Mankowski, J.L., Baldwin, W.M. III, Faraday, N., and Lowenstein, C.J. (2005). Regulation of platelet granule exocytosis by S-nitrosylation. Proc. Natl. Acad. Sci. USA 102, 3782-3787.
55. Nichols, B.J., Ungermann, C., Pelham, H.R., Wickner, W.T., and Haas, A. (1997). Homotypic vacuolar fusion mediated by t-and v-SNAREs. Nature 387, 199-202.
56. Olson, T.S. and Ley, K. (2002). Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R7-R28.
57. Papapetropoulos, A., Rudic, R.D., and Sessa, W.C. (1999). Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc. Res. 43, 509-520.
58. Patel, S. and Latterich, M. (1998). The AAA team: related ATP-ases with diverse functions. Trends Cell Biol. 8, 65-71.
59. Pawloski, J.R., Swaminathan, R.V., and Stamler, J.S. (1998). Cell-free and erythrocytic S-nitrosohemoglobin inhibits human platelet aggregation. Circulation 97, 263-267.
60. Peng, H.B., Libby, P., and Liao, J.K. (1995). Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270, 14214-14219.
61. 2+ uptake into platelet membrane vesicles. Biochem. Biophys. Res. Commun. 222, 780-785.
62. Pigazzi, A., Heydrick, S., Folli, F., Benoit, S., Michelson, A., and Loscalzo, J. (1999). Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J. Biol. Chem. 274, 14368-14375.
63. Polgar, J. and Reed, G.L. (1999). A critical role for N-ethylmaleimide-sensitive fusion protein (NSF) in platelet granule secretion. Blood 94, 1313-1318.
64. Polgar, J., Chung, S.H., and Reed, G.L. (2002). Vesicle-associated membrane protein 3 (VAMP-3) and VAMP-8 are present in human platelets and are required for granule secretion. Blood 100, 1081-1083.
65. Radomski, M.W. and Moncada, S. (1993). Regulation of vascular homeostasis by nitric oxide. Thromb. Haemost. 70, 36-41.
66. Radomski, M.W., Palmer, R.M., and Moncada, S. (1987). Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2, 1057-1058.
67. Reed, G.L., Houng, A.K., and Fitzgerald, M.L. (1999). Human platelets contain SNARE proteins and a Sec1p homologue that interacts with syntaxin 4 and is phosphorylated after thrombin activation: implications for platelet secretion. Blood 93, 2617-2626.
68. Rothman, J.E. (1994). Mechanisms of intracellular protein transport. Nature 372, 55-63.
69. Rowe, T. and Balch, W.E. (1997). Membrane fusion. Bridging the gap by AAA ATPases. Nature 388, 20-21.
70. Rubanyi, G.M. (1991). Endothelium-derived relaxing and contracting factors. J. Cell Biochem. 46, 27-36.
71. Rudic, R.D., Shesely, E.G., Maeda, N., Smithies, O., Segal, S.S., and Sessa, W.C. (1998). Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 101, 731-736.
72. Sogo, N., Magid, K.S., Shaw, C.A., Webb, D.J., and Megson, I.L. (2000). Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem. Biophys. Res. Commun. 279, 412-419.
73. Sollner, T.H. and Sequeira, S. (2003). S-Nitrosylation of NSF controls membrane trafficking. Cell 115, 127-129.
74. Sollner, T., Whiteheart, S.W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J.E. (1993). SNAP receptors implicated in vesicle targeting and fusion. Nature 362, 318-324.
75. Stamler, J.S., Singel, D.J., and Loscalzo, J. (1992). Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902.
76. Tsikas, D., Ikic, M., Tewes, K.S., Raida, M., and Frolich, J.C. (1999). Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets. FEBS Lett. 442, 162-166.
77. Whiteheart, S.W., Rossnagel, K., Buhrow, S.A., Brunner, M., Jaenicke, R., and Rothman, J.E. (1994). N-Ethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of ATP is required for membrane fusion. J. Cell Biol. 126, 945-954.
78. Xu, D., Rovira, I.I., and Finkel, T. (2002). Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev. Cell 2, 251-252.
79. Yu, R.C., Hanson, P.I., Jahn, R., and Brunger, A.T. (1998). Structure of the ATP-dependent oligomerization domain of N-ethylmaleimide sensitive factor complexed with ATP. Nat. Struct. Biol. 5, 803-811.